At a glance
- Originator Eli Lilly and Company
- Class Amino acids; Anti-ischaemics; Heterocyclic bicyclo compounds; Neuroprotectants; Small molecules
- Mechanism of Action Glutamate agonists; Metabotropic glutamate receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neurological disorders; Schizophrenia
Most Recent Events
- 09 Dec 2005 Discontinued - Preclinical for Neurological disorders in United Kingdom (unspecified route)
- 09 Dec 2005 Discontinued - Preclinical for Neurological disorders in USA (unspecified route)
- 09 Dec 2005 Discontinued - Preclinical for Schizophrenia in USA (unspecified route)